Prime Medicine seeks approval for gene-editing treatment after trial with two patients. The Prime Medicine app will be tested by the FDA, which has promised to speed up new ways to edit genes. Some recent methods have been rejected by the FDA. (Note: Available search results do not include the direct text of the Prime Medicine article provided, so the summary is based solely on the content provided without additional facts.)